Gyros Protein Technologies Logo

Accelerating workflows for immunoassay and peptide researchers

Explore Gyrolab solutions
Explore PurePep solutions
Immunoassays and Peptide Synthesis
Peptide Researcher

Biotherapeutic development demands flexible and automated platforms that deliver accurate, replicable results at scale, from discovery to manufacture.

Our proven platforms deliver unmatched precision and efficiency

Achieve biotherapeutic development goals faster with automated platforms that ensure quality, throughput and data consistency.

Resource articles

Precision meets efficiency: Get insights into how Gyrolab and PurePep solutions innovate biotherapeutic drug development.

tout-test

PEPTIDES

Three bottlenecks slowing down your peptide purification workflow

Discover how HPLC delays, precipitation issues, and high costs slow peptide purification—plus a precipitation-free solution that saves 3-4 days per cycle.
Using automated immunoassays for HCP analysis

IMMUNOASSAYS

Using Automated Immunoassays for HCP Analysis in Early Bioprocess Development

This article outlines Boehringer Ingelheim's structured workflow integrating immunoassays and mass-spectrometry for efficient HCP monitoring in biopharmaceutical development.
Case Study

PEPTIDES

In-house peptide synthesis reduces costs and shortens turnaround times | Case Study with Ab Biotechnology

Discover how Ab Biotechnology cut timelines by 50% and achieved a 2-year ROI by adopting in-house peptide synthesis with Gyros Protein Technologies. 
The Golden Age of Peptide Therapeutics

PEPTIDES

The Golden Age of Peptide Therapeutics: Insights from CatSci’s Simon Tyler

Discover why we're in the golden age of peptide therapeutics with insights from CatSci's Simon Tyler on market trends and the future of peptide science.

Your guide to miniaturized immunoassays for biotherapeutics thumb

IMMUNOASSAYS

Your guide to miniaturized immunoassays for biotherapeutics

Discover the advantages of automated, miniaturized immunoassays across
the drug development pathway from pre-clinical to bioprocessing
tout-test

PEPTIDES

From Lab to Scale: A Game-Changing Approach to Peptide Purification in GLP-1 Manufacturing

Discover how innovative PEC technology transforms GLP-1 peptide manufacturing, offering a cost-effective alternative to traditional purification methods.
CGT wp

IMMUNOASSAYS

Increasing productivity in cell and gene therapy bioprocessing with fast and reliable immunoassays

This white paper provides an overview of the viral vector landscape and its use in cell and gene therapy, with a focus on lentiviral vectors and adeno-associated viral (AAV) vectors. 
tout-test

IMMUNOASSAYS

Article - Development of anti-AAV assay for detection of pre-existing AAV immunity

This article presents an assay to detect pre-existing AAV immunity of subjects in pre-clinical studies, aiding subject selection and improving gene therapy research efficiency.

tout-test

IMMUNOASSAYS

AN: Accelerate throughput in therapeutic antibody development with an improved generic PK assay

This application note helps research scientists optimize preclinical pharmacokinetics studies by highlighting improved assay flexibility, sensitivity, and sample efficiency using the Gyrolab® 2G Generic PK Kit
White Paper Anti-drug antibody studies

IMMUNOASSAYS

White Paper: Anti-drug antibody studies

Lear how to maximize drug tolerance and minimize sample and reagent consumption
tout-test

IMMUNOASSAYS

AN: Selective and robust biomarker quantification using Gyrolab human cytokine kit reagents

This application note guides research scientists in using Gyrolab® single-analyte cytokine assays for fast, automated, and robust biomarker quantification. Detection of 5 human cytokines, IL-4, IL-6, IL-10, IFN-gamma, and TNF-alpha in single-analyte automated assays on the Gyrolab platform evaluating selectivity.